PMID: 9164677May 1, 1997Paper

Mechanism of action of a tyrphostin, 3,4-dihydroxy-alpha-cyanothiocinnamamide, in breast cancer cell growth inhibition involves the suppression of cyclin B1 and the functional activity of cyclin B1/p34cdc2 complex

Breast Cancer Research and Treatment
C A FaalandT J Thomas

Abstract

Tyrphostins are a group of compounds specifically targeted for the inhibition of tyrosine phosphorylation in signal transduction pathways. We studied the effects of a tyrphostin, 3,4-dihydroxy-alpha-cyanothiocinnamamide (tyrphostin-47), on hormone-responsive MCF-7 and hormone-unresponsive MCF-7-5C cell growth by DNA analysis for a period of 10 days. The growth of both cell lines was inhibited by this drug at 50 and 100 microM concentrations. Flow cytometric analysis showed that tyrphostin treatment caused a significant delay in the progression of MCF-7 cells through G1 and S phases of the cell cycle. The level of cyclin B1, a component of the mitosis promoting factor (MPF), was reduced by 90% in the presence of 100 microM tyrphostin. The other component of MPF, p34cdc2 kinase, was not affected; however, its functional activity was dramatically reduced, as determined by histone H1 phosphorylation assay. In contrast, G1 cyclins (D1 and E) and tyrosine kinase activity were not markedly affected by tyrphostin-47, as determined by Western immunoblot detection with specific antibodies. Our results suggest that a possible mechanism of tyrphostin action in breast cancer cells might involve the suppression of cyclin B1 and inhibition of...Continue Reading

References

Jul 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·H HaiglerS Cohen
Dec 1, 1992·Molecular and Cellular Endocrinology·S Y JiangV C Jordan
Nov 1, 1992·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·A Levitzki
Jan 1, 1992·Annual Review of Cell Biology·S I Reed
Jan 1, 1992·Critical Reviews in Oncology/hematology·R ClarkeM E Lippman
Jun 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·B CohenB S Schaffhausen
May 17, 1991·Cell·Y XiongD Beach
Jan 1, 1990·Progress in Growth Factor Research·A F Wilks
Apr 1, 1990·Current Opinion in Cell Biology·M Dorée
Oct 1, 1989·Journal of Medicinal Chemistry·A GazitA Levitzki
May 25, 1989·Nature·A W Murray, M W Kirschner
May 1, 1986·Experimental Cell Research·G Carpenter, J G Zendegui
Jan 1, 1988·Annual Review of Biochemistry·Y Yarden, A Ullrich
Jan 1, 1994·Breast Cancer Research and Treatment·N NormannoD S Salomon
Dec 3, 1993·Cell·T Hunter
Mar 26, 1993·Science·M Ohtsubo, J M Roberts
Feb 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·K Keyomarsi, A B Pardee
Jun 18, 1993·Cell·C J Sherr
Apr 2, 1996·Proceedings of the National Academy of Sciences of the United States of America·W F De AzevedoS H Kim
Feb 1, 1996·Carcinogenesis·T T WangJ M Phang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.